Literature DB >> 19914211

Synergistic augmentation of inflammatory cytokine productions from murine mast cells by monomeric IgE and toll-like receptor ligands.

Hiroshi Takenaka1, Hiroko Ushio, François Niyonsaba, Sumanasiri T M Jayawardana, Suto Hajime, Shigaku Ikeda, Hideoki Ogawa, Ko Okumura.   

Abstract

Simultaneous activation of murine mast cells by monomeric IgE and toll-like receptor (TLR) ligands was examined. Inflammatory cytokine production elicited by the binding of IgE in the absence of antigen, was further enhanced by the addition of lipopolysaccharide (LPS) or peptidoglycan (PGN). Enhancement by LPS or PGN on cytokine production was mediated by TLR4 and TLR2, respectively, since TLR4- and TLR2-deficient mast cells did not show synergistic activation by monomeric IgE and LPS/PGN. Synergistic activation of mast cells was obtained via phosphorylation of several mitogen-activated protein kinases (MAPK). Furthermore, MAPK inhibitors, significantly attenuated the augmentation of inflammatory cytokine production by monomeric IgE and LPS or PGN. Altogether, these results suggest that simultaneous TLR activation of mast cells with IgE molecules, particularly highly cytokinergic (HC) IgE, might contribute to the exacerbation of allergic diseases associated with infection even in the absence of a specific antigen. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914211     DOI: 10.1016/j.bbrc.2009.11.082

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  IgE-dependent sensitization increases responsiveness to LPS but does not modify development of endotoxin tolerance in mast cells.

Authors:  Jaciel Medina-Tamayo; Alfredo Ibarra-Sánchez; Alejandro Padilla-Trejo; Claudia González-Espinosa
Journal:  Inflamm Res       Date:  2010-07-13       Impact factor: 4.575

2.  The role of SHIP in the development and activation of mouse mucosal and connective tissue mast cells.

Authors:  Jens Ruschmann; Frann Antignano; Vivian Lam; Kim Snyder; Connie Kim; Martha Essak; Angela Zhang; Ann Hsu-An Lin; Raghuveer Singh Mali; Reuben Kapur; Gerald Krystal
Journal:  J Immunol       Date:  2012-03-19       Impact factor: 5.422

3.  IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice.

Authors:  Jing Wang; Xiang Cheng; Mei-Xiang Xiang; Mervi Alanne-Kinnunen; Jian-An Wang; Han Chen; Aina He; Xinghui Sun; Yan Lin; Ting-Ting Tang; Xin Tu; Sara Sjöberg; Galina K Sukhova; Yu-Hua Liao; Daniel H Conrad; Lunyin Yu; Toshiaki Kawakami; Petri T Kovanen; Peter Libby; Guo-Ping Shi
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

4.  Inhibitory effects of methamphetamine on mast cell activation and cytokine/chemokine production stimulated by lipopolysaccharide in C57BL/6J mice.

Authors:  Li Xue; Yan Geng; Ming Li; Yao-Feng Jin; Hui-Xun Ren; Xia Li; Feng Wu; Biao Wang; Wei-Ying Cheng; Teng Chen; Yan-Jiong Chen
Journal:  Exp Ther Med       Date:  2018-02-05       Impact factor: 2.447

5.  Impaired Toll-like receptor 2-mediated Th1 and Th17/22 cytokines secretion in human peripheral blood mononuclear cells from patients with atopic dermatitis.

Authors:  Yangyang Yu; Yarui Zhang; Jie Zhang; Xia Dou; Hong Yang; Yong Shao; Kepeng Wang; Bo Yu; Wei Zhang; Hang Yung Alaster Lau
Journal:  J Transl Med       Date:  2015-12-18       Impact factor: 5.531

6.  Differential effects of the Toll-like receptor 2 agonists, PGN and Pam3CSK4 on anti-IgE induced human mast cell activation.

Authors:  Yangyang Yu; Kwok Ho Yip; Issan Yee San Tam; Sze Wing Sam; Chun Wai Ng; Wei Zhang; Hang Yung Alaster Lau
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

7.  miRNA-221-3p Enhances the Secretion of Interleukin-4 in Mast Cells through the Phosphatase and Tensin Homolog/p38/Nuclear Factor-kappaB Pathway.

Authors:  Yao Zhou; Qianyuan Yang; Hong Xu; Jiamin Zhang; Huan Deng; Haiyan Gao; Jin Yang; Deyu Zhao; Feng Liu
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.